Activated mTORC1-SIRT6 Mediates Myofibroblast Differentiation and Idiopathic Pulmonary Fibrosis
Cited by 0
Related Papers
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
Discovery of a new class of integrin antibodies for fibrosis
|Scientific Reports|2021|68
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route
|Journal of Medicinal Chemistry|2021|42